Prokidney (PROK) Receivables - Accured (2023 - 2026)

Prokidney (PROK) has 4 years of Receivables - Accured data on file, last reported at $1.0 million in Q1 2026.

• On a quarterly basis, Receivables - Accured fell 41.1% year-over-year to $1.0 million in Q1 2026; TTM through Mar 2026 was $1.0 million, a 41.1% decrease from a year earlier, with the FY2025 full-year figure at $1.1 million, down 53.94% from the prior year.
• Receivables - Accured for Q1 2026 stood at $1.0 million, down from $1.1 million in the prior quarter.
• Over the last five years, Receivables - Accured for PROK reached as high as $8.1 million in Q2 2023 and fell as low as $714000.0 in Q3 2023.
• Historically, Receivables - Accured has averaged $2.7 million across 4 years, with a median of $1.8 million in 2025.
• Across the five-year window, Receivables - Accured surged 614.57% in 2024 and tumbled 75.75% in 2025, its largest moves.
• Year by year, Receivables - Accured stood at $1.4 million in 2023, then soared by 77.96% to $2.4 million in 2024, then tumbled by 53.94% to $1.1 million in 2025, then decreased by 8.43% to $1.0 million in 2026.
• Per Business Quant data, the three most recent Receivables - Accured figures were $1.0 million in Q1 2026, $1.1 million in Q4 2025, and $1.2 million in Q3 2025.